AIFinancial Postabout 4 hours ago
Murchinson Slams Nano Dimension's Infinite Epigenetics Deal
1 min read
Murchinson, a Nano Dimension shareholder with 7.4% of shares, criticized the board's decision to pursue a transaction with Infinite Epigenetics. The firm called the deal a misallocation of resources that would dilute existing shareholders. Murchinson also noted the conference call offered no shareholder Q&A opportunity.
Level
Hype check
Tap to vote and see what everyone thinks.
